CNN

In controversial decision, FDA approves first new Alzheimer’s disease drug in nearly 20 years

The US Food and Drug Administration on Monday approved the use of the experimental drug aducanumab for early phases of Alzheimer’s disease – despite an FDA advisory committee concluding last year that ...
CNN

New Alzheimer’s drug aducanumab: cost, side effects, timeline and other questions answered

Patients and their families are starting to inquire about the new Alzheimer’s drug approved this week by the US Food and Drug Administration. Shipments of the medication are expected to go out in just ...
Health Affairs

Medicare ‘Coverage With Evidence Development’ For Aducanumab? How Might It Work?

In the wake of the Food and Drug Administration’s (FDA’s) controversial decision to approve aducanumab for Alzheimer’s disease, how will, and how should, Medicare respond? We propose a coverage with ...
FierceBiotech

Editor's Corner—The FDA's decision on aducanumab will drag down innovation for years to come

The amyloid theory just won’t die. In fact, by approving Biogen's new Alzheimer's disease drug, the FDA has just resurrected it for a long and healthy future. This is great news for Biogen, but it ...